Free on-demand webinar
CGMP & Quality Management for OTC Manufacturers
6 Critical Compliance Questions in Areas of Regulatory Focus
45-minute presentation with 15-minute Q&A.
The FDA has stepped up inspections of manufacturing facilities producing over-the-counter (OTC) drugs and similar health products following a number of repeatedly observed current good manufacturing practice (CGMP) deficiencies.
This has resulted in multiple warning letters, import alerts, and recalls.
Most of these issues demonstrate fundamental problems related to the quality management system (QMS).
Watch this free recorded webinar and learn the six key questions for assessing CGMP compliance and quality management related to the issues being observed in OTC manufacturing facilities.
What you'll receive in this presentation: